2023-07-04
AbbVie Sues BeiGene over Imbruvica Patent
On June 15, AbbVie filed a lawsuit against BeiGene, claiming that BeiGenes Brukinsa has infringed a patent on its blood cancer drug Imbruvica. The disputed patent, which relates to the use of BTK inhibitors, was issued on June 13, just two days before Abb
